http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0002542-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca02d91b6778fff3ac0aedb305ddd1cc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4468
filingDate 1999-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38a0a0889bc9361846b8a5f26c6346b9
publicationDate 2000-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0002542-A3
titleOfInvention Agents with an antidepressive effect containing pramipexol and an additional antidepressant drug
abstract The invention relates to the use of 2-amino-4,5,6,7-tetrahydro-6-propylamino-benzothizole (pramipexol), its (+) or (-) enantiomers or one of its pharmacologically compatible salts, combined with sertralin, for treating depression and depressive conditions more effectively.
priorityDate 1998-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9413287-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9936064-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9824446-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226454548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4885
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226554349

Total number of triples: 42.